A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Summary

A Phase I study of the Safety and immunogenicity of MVA85A in healthy Gambian volunteers

Timeline

Start

2003-03

Primary completion

—

Completion

2005-07

Publications

• Results Ibanga HB, Brookes RH, Hill PC, Owiafe PK, Fletcher HA, Lienhardt C, Hill AV, Adegbola RA, McShane H. Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design. Lancet Infect Dis. 2006 Aug;6(8):522-8. doi: 10.1016/S1473-3099(06)70552-7.
• Brookes RH, Hill PC, Owiafe PK, Ibanga HB, Jeffries DJ, Donkor SA, Fletcher HA, Hammond AS, Lienhardt C, Adegbola RA, McShane H, Hill AV. Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa. PLoS One. 2008 Aug 13;3(8):e2921. doi: 10.1371/journal.pone.0002921.

Drugs

Indications